Table 4 Relationship between SLC7A11 or nuclear NRF2 expression and clinical response to CRT
| Â | Â | Treatment response | Â | |
|---|---|---|---|---|
|  |  | CR + PR | SD + PD | P-value |
Nuclear NRF2 | Low expression (%) | 49 (74.2) | 17 (25.8) | 0.002 |
High expression (%) | 29 (47.5) | 32 (52.5) | Â | |
SLC7A11 | Low expression (%) | 46 (70.8) | 19 (29.2) | 0.027 |
High expression (%) | 32 (51.6) | 30 (48.4) | Â | |